Challenges of conducting a placebo-controlled trial for dysmenorrhea in adolescents. Academic Article uri icon

Overview

abstract

  • We recruited adolescents to study oral contraceptives versus placebo for dysmenorrhea. We anticipated high discontinuation and concerns about safety, side effects, and sexual behavior. Treatment discontinuation (11%) and loss to follow-up (1%) were lower than expected. The most common reason for nonenrollment was logistical issues (63%). Most participants remained abstinent.

publication date

  • July 10, 2006

Research

keywords

  • Contraceptives, Oral
  • Dysmenorrhea

Identity

Scopus Document Identifier

  • 33748524875

PubMed ID

  • 16982402

Additional Document Info

volume

  • 39

issue

  • 4